Efficacy [qlco]    
Safeties [hcpp]    
patient [podg]    
Advance [qlco]    
Hepatocellular carcinoma [neop]    
Phase III Trial [resa]    
Background [cnce]    
Aim [idcn]    
Hepatocellular carcinoma [neop]    
Assess [hlca]    
RANDOM [resa]    
Protocol [inpr]    
Sharp [fndg]    
Trial [resa]    
Overall [inpr]    
Survival [acty]    
patient [podg]    
Advance [qlco]    
Hepatocellular carcinoma [neop]    
Trial [resa]    
patient [podg]    
Well [qlco]    
Preservation [lbpr]    
Liver function [ortf]    
Child [aggp]    
RANDOM [resa]    
To [qlco]    
Receive [qlco]    
mg% [qnco]    
match [resa]    
placebo [topp]    
Oral [spco]    
i d [topp]    
Continual [idcn]    
Basis [ftcn]    
Hepatocellular carcinoma [neop]    
Heterogeneity [qlco]    
Disease [dsyn]    
baseline [bodm]    
*^patient [podg]    
Characteristic [qlco]    
Affect [menp]    
Individual [popg]    
Response [orga]    
treatment [ftcn]    
Comprehension [qlco]    
Series [qnco]    
subgroup [virs]    
Analysis [lbpr]    
Data [idcn]    
Sharp [fndg]    
Trial [resa]    
Analyzed [resa]    
To [qlco]    
If [qlco]    
baseline [bodm]    
*^patient [podg]    
Characteristic [qlco]    
Efficacy [qlco]    
Safeties [hcpp]    
Method [inpr]    
Five [qnco]    
subgroup [virs]    
Domain [ftcn]    
Assess [acty]    
disease etiology [ftcn]    
Tumor Burden [diap]    
Performance Status [clna]    
stage tumor [clna]    
Prior Therapy [clna]    
Overall [inpr]    
Survival [acty]    
Time [tmco]    
progress [patf]    
disease rate [qnco]    
Control [grup]    
Safeties [hcpp]    
Assess [acty]    
subgroup [virs]    
Domain [ftcn]    
Result [ftcn]    
subgroup [virs]    
Analysis [lbpr]    
Show [inpr]    
Improved [qlco]    
median [spco]    
Overall [inpr]    
Survival [acty]    
Compare [acty]    
placebo [topp]    
reflect [menp]    
Hazard Ratio [qnco]    
Similar [qlco]    
Complete [qlco]    
Cohort [popg]    
69 [inpr]    
Improved [qlco]    
median [spco]    
Tip [medd]    
/40 [tmco]    
Positive [qnco]    
patient [podg]    
1+ [qnco]    
disease rate [qnco]    
Control [grup]    
Result [ftcn]    
limit [ftcn]    
Small [qnco]    
Patient number [inpr]    
Subset [clas]    
Most [qnco]    
Common [qnco]    
Grade III [qlco]    
Adverse event [fndg]    
include [ftcn]    
Diarrhea [sosy]    
Hand skin [bpoc]    
Foot [bpoc]    
Reaction [ftcn]    
Fatigue [sosy]    
Incidence [qnco]    
Not [ftcn]    
subgroup [virs]    
Conclusion [idcn]    
subgroup [virs]    
Analysis [lbpr]    
Show [inpr]    
Improved [qlco]    
median [spco]    
Overall [inpr]    
Survival [acty]    
disease rate [qnco]    
Control [grup]    
Compare [acty]    
placebo [topp]    
patient [podg]    
Advance [qlco]    
Hepatocellular carcinoma [neop]    
disease etiology [ftcn]    
baseline [bodm]    
Tumor Burden [diap]    
Performance Status [clna]    
stage tumor [clna]    
Prior Therapy [clna]    
[c] [qnco]    
European [popg]    
Associate [menp]    
studies [mnob]    
Liver [bpoc]    
Published [ocac]    
Rights [qlco]    
Reservation [acty]    
